Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

UREAPLASMA DIFFERENTIAL BASAL AGAR MED.

K-Number: K771686 · 1977-10-28

ApplicantGibco Laboratories Life Technologies, Inc.
Decision Date1977-10-28
Product CodeJSH
Advisory CommitteeMI
DecisionSubstantially Equivalent

Device Summary

UREAPLASMA DIFFERENTIAL BASAL AGAR MED. is the device name listed in this FDA 510(k) record. The listed applicant is Gibco Laboratories Life Technologies, Inc.. It received FDA 510(k) clearance on 1977-10-28 under 510(k) number K771686. The device is classified under product code JSH. It was reviewed by the MI advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the UREAPLASMA DIFFERENTIAL BASAL AGAR MED.?

UREAPLASMA DIFFERENTIAL BASAL AGAR MED. is a medical device that received FDA 510(k) clearance on 1977-10-28. The listed applicant is Gibco Laboratories Life Technologies, Inc.. The 510(k) number is K771686.

When did UREAPLASMA DIFFERENTIAL BASAL AGAR MED. receive FDA 510(k) clearance?

UREAPLASMA DIFFERENTIAL BASAL AGAR MED. received FDA 510(k) clearance on 1977-10-28, under 510(k) number K771686.

Who is the listed applicant for UREAPLASMA DIFFERENTIAL BASAL AGAR MED.?

The FDA 510(k) record lists Gibco Laboratories Life Technologies, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for UREAPLASMA DIFFERENTIAL BASAL AGAR MED.?

The FDA product code for UREAPLASMA DIFFERENTIAL BASAL AGAR MED. is JSH.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITINGNCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITINGNCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDEDNCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Other records listing Gibco Laboratories Life Technologies, Inc. as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K871855SORBITOL MACCONKEY (SMAC) AGAR, DRI & PRE-FORMK871541MARTIN-LEWIS AGAR W/REDUCED VANCOMYCIN C0226K870134MCBRIDE LISTERIA AGAR W/CYCLOHEXIMIDE, DRI & PREK864755PSEUDOMONAS CEPACIA SELECTIVE AGAR, DRI & PRE-FORMK864014LOMBARD DOWELL AGAR BASEK863821MUELLER HINTON AGAR W/4%NACL AND OXACILLIN

View all 67 devices →

Related Devices (Code: JSH)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K881553RUSSELL DOUBLE SUGAR AGARAcumedia Manufacturers, Inc.K881559UREA AGAR BASEAcumedia Manufacturers, Inc.K881486DNASE TEST AGARAcumedia Manufacturers, Inc.K881540FLO AGARAcumedia Manufacturers, Inc.K881551PHENOL RED BROTH BASEAcumedia Manufacturers, Inc.K881560UREA BROTHAcumedia Manufacturers, Inc.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑